Detail of the clinical trial
| Title of the trial | A phase I/II study of 177Lu-HH1 (BetalutinTM) radioimmunotherapy for treatment of relapsed CD37+ non-Hodgkin lymphoma |
|---|---|
| EudraCT number | 2011-000033-36 |
| Protocol number | LYMRIT-37-01 |
| Sponsor | Nordic Nanovector AS,Kjelsasveien 168B,Oslo,NO-0884, Norway |
| Indications | Hemato-oncology |
| Diagnosis | non-Hodgkin lymphoma |
| Population in clinical trial |
Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2014 |
| Date of approval by Institute (SÚKL) | 2.4.2015 |
| Date of approval by EC | 19.1.2015 |
| Date of initiation CT in ČR | 6.4.2016 |
| Date of ending CT in ČR | 20.7.2022 |
| Notice | |
| Sites |
FNKV ,Interní hematologická klinika,Šrobárova 10,Praha 10,100 34 (discontinued) FNsP Ostrava,Klinika hematoonkologie,17 listopadu 1790,Ostrava, Poruba,708 52 FN Olomouc,Hemato-onkologická klinika,I.P. Pavlova 6,Olomouc,779 00 FN Brno,Interní hematologická a onkologická klinika,Jihlavská 20,Brno,625 00 (discontinued) VFN v Praha,I. interní klinika - klinika hematologie,U Nemocnice 2,Praha 2,128 08 (discontinued) |
cz